Downloads: 497

Files in This Item:
File Description SizeFormat 
000355341.pdf350.52 kBAdobe PDFView/Open
Title: Refractoriness of intestinal Behçet's disease with myelodysplastic syndrome involving trisomy 8 to medical therapies - our case experience and review of the literature.
Authors: Toyonaga, Takahiko
Nakase, Hiroshi  KAKEN_id
Matsuura, Minoru  kyouindb  KAKEN_id
Minami, Naoki
Yamada, Satoshi
Honzawa, Yusuke  kyouindb  KAKEN_id
Hukata, Norimasa
Yoshino, Takuya  KAKEN_id
Chiba, Tsutomu  kyouindb  KAKEN_id
Okazaki, Kazuichi
Author's alias: 豊永, 貴彦
仲瀬, 裕志
Keywords: Behçet’s disease
Myelodysplastic syndrome
Trisomy 8
Biologic agent

Issue Date: 2013
Publisher: Karger
Journal title: Digestion
Volume: 88
Issue: 4
Start page: 217
End page: 221
Abstract: Background/Aims: Gastrointestinal lesions of Behçet's disease (BD) are often refractory to medical therapy and sometimes result in serious comorbidities such as gastrointestinal perforation and massive bleeding. There are several reports of patients with BD comorbid with myelodysplastic syndrome (MDS) involving trisomy 8 that frequently have intestinal lesions refractory to conventional medical therapy. Little is known about the efficacy of infliximab (IFX) for these intestinal lesions. Methods: We present 2 cases of intestinal BD with MDS involving trisomy 8 who did not respond to IFX, and review previous reports of BD with MDS involving trisomy 8 concerning their responsiveness to conventional medical therapy. Results: Among 31 previously reported cases that received medical treatment for BD, 19 (61.3%) showed temporary improvement of the BD symptoms, 9 (29.0%) deteriorated, and 3 (9.7%) showed no change. All of the 9 cases that showed deterioration had intestinal lesions. Our 2 cases failed to respond to IFX, resulting in a poor prognosis. Conclusions: IFX might not be effective for improving intestinal BD comorbid with MDS involving trisomy 8. Trisomy 8 is associated with the BD prognosis and refractoriness to conventional medical therapy.
Rights: © 2013 S. Karger AG, Basel
This is not the published version. Please cite only the published version.
DOI(Published Version): 10.1159/000355341
PubMed ID: 24247154
Appears in Collections:Journal Articles

Show full item record

Export to RefWorks

Export Format: 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.